Cardiological Society of India, Cardiology Update 2014.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Chopra, HK
Otros Autores: Ramakrishnan, S., Pancholia, AK
Formato: Electrónico eBook
Idioma:Inglés
Publicado: DL : Jaypee Brothers, Medical Publishers, 2015.
Temas:
Cardiology.
Cardiovascular system > Diseases.
Cardiovascular Diseases
Cardiology
Cardiologie.
Appareil cardiovasculaire > Maladies.
Cardiovascular system > Diseases
India
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Intro
  • Prelims
  • Section- I
  • Chapter-001_Development of Cardiology in India Where are We Today
  • Chapter-002_Antiplatelets and Antithrombotics after DES What Next
  • Chapter-003_Impact of Kidney Disease on the Outcome and Management of Acute Coronary Syndrome
  • Chapter-004_Antiplatelet Drug-resistance in Asian Population
  • Chapter-005_Gold or Old Standard New Insights on Aspirin in Cardiovascular Diseases (CVD) Prevention
  • Chapter-006_Changing Landscape of Oral Anticoagulants The Last Pieces of the Puzzle
  • Chapter-007_Top Ten Most Promising New and Future Therapies in Cardiology Status Report 2014
  • Chapter-008_A Cardiologists Viewpoint on Gliptins The New Star on the Horizon of Diabetes
  • Chapter-009_Statins as Primary Preventive Strategy
  • Chapter-010_Management of Atherogenic Dyslipidemia Triad Indian Perspective
  • Chapter-011_Lipid Management Beyond Statins Targeting HDL and TG Challenges 2014
  • Chapter-012_Management of Hypertriglyceridemia and Cardiovascular Risk Reduction
  • Chapter-013_Beta-blockers and Coronary Artery Disease Status 2014
  • Chapter-014_Statin Guidelines Controversies to Consensus (What to Follow in 2014)
  • Chapter-015_ARBs and CVD Protection New Dimension 2014
  • Chapter-016_Amiodarone and Cardiovascular Disease Protection Clinical Implications 2014
  • Chapter-017_Gaps and Challenges in Antiplatelet Therapy Indian Perspective
  • Chapter-018_Triple Antiplatelet Therapy in Acute Coronary Syndrome in 2014
  • Chapter-019_Drug-Drug Interactions in Cardiology
  • Chapter-020_Pharmacoinvasive Strategy in the Treatment of STEMI
  • Chapter-021_Post-PTCA and Post-CABG Care What is New in 2014
  • Chapter-022_Acute Coronary Syndrome Management Strategies Recent Advances 2014
  • Section- II
  • Chapter-023_Genetics and Coronary Artery Disease-Challenges
  • Chapter-024_Coronary Artery Disease Risk Factor Stratification.
  • Chapter-025_Vitamin D and Cardiovascular Disease
  • Chapter-026_Tobacco and Heart
  • Chapter-027_Stress and Heart
  • Chapter-028_Role of Psychosocial Factors and Relaxation Techniques in the Etiology and Prevention of Cardiovascular Diseases
  • Chapter-029_Trans Fat and Cardiovascular Disease
  • Chapter-030_Homocysteine and Coronary Artery Disease
  • Chapter-031_State-of-the-art Review on Metabolic Syndrome, Diabetes, and Cardiovascular Disease
  • Chapter-032_Vulnerable Plaque in a Vulnerable Patient How to Manage
  • Chapter-033_Microvascular CAD Management Issues 2014
  • Chapter-034_Hormone Replacement Therapy and Heart
  • Chapter-035_Lifestyle and Coronary Artery Disease
  • Chapter-036_Using Health Behavior Change Theory to Guide Health Promotion to Prevent Noncommunicable Diseases in India
  • Section- III
  • Chapter-037_Nutrition and Heart
  • Chapter-038_CoQ10 and CVD Risk Reduction 2014
  • Chapter-039_CoQ10 in CHF and CAD Potentials and Challenges Ahead
  • Chapter-040_Edible Oils in Cardiovascular Disease Protection
  • Chapter-041_Management of Obesity By Optimizing Nutrition
  • Section- IV
  • Chapter-042_Coronary Artery Disease and Biomarkers
  • Chapter-043_Electrocardiogram Pitfalls in Diagnosis and Artifacts
  • Chapter-044_Echocardiography Beginning, Present, and FutureEchocardiography Beginning, Present, and Future
  • Chapter-045_Stress Echocardiography and Coronary Artery Disease
  • Chapter-046_Stress Myocardial Perfusion Imaging
  • Chapter-047_LV Diastolic Function Evaluation What is Practical
  • Chapter-048_Echocardiographic Evaluation in Elderly What is New
  • Chapter-049_Myocardial Contrast Echocardiography Usefulness and Pitfalls
  • Chapter-050_Echocardiography and Post-MI Complications
  • Chapter-051_Three-dimensional Echocardiography Is it Superior to Two-dimensional Echocardiography for Valvular Heart Disease.
  • Chapter-052_Strain and Strain Rate Imaging Clinical Implications 2014
  • Chapter-053_Need of Cardiac Evaluation in Obesity
  • Section- V
  • Chapter-054_Management of Acute Myocardial Infarction in 2014
  • Chapter-055_Thrombolysis in Acute Myocardial Infarction Which Agent is the Right Choice
  • Chapter-056_Primary Angioplasty in 2014
  • Chapter-057_Thrombus Aspiration During Primary Percutaneous Coronary Angioplasty
  • Chapter-058_Cardiogenic Shock in Acute Myocardial Infarction
  • Chapter-059_Post-MI Risk Stratification and Cardiac Rehabilitation
  • Chapter-060_Revascularization in Acute Myocardial Infarction Patients 24 Hours after Thrombolysis
  • Chapter-061_Thrombolytic Therapy in STEMI Interventions
  • Section- VI
  • Chapter-062_Chronic Total Occlusion (CTO) Strategies and Wiring Techniques
  • Chapter-063_Chronic Total Occlusion Management Strategies 2014
  • Chapter-064_Radial Angioplasty Tips and Tricks
  • Chapter-065_Guidelines for PCI 2014 Training for Percutaneous Coronary Intervention Appropriateness, Indications and Directions
  • Chapter-066_Complex Coronary Angioplasty Procedure Tips and Tricks
  • Chapter-067_Drug-eluting Stents Differing Platforms and Outcome
  • Chapter-068_Role of Rotational Atherectomy in Percutaneous Coronary Interventions
  • Chapter-069_Can We Predict Stent Thrombosis and So Prevent It
  • Chapter-070_Biovascular Scaffolds New Dimension 2014
  • Chapter-071_Indigenous Stents Examining the Clinical Data on New Technologies
  • Chapter-072_Hybrid Coronary Revascularization An Integrated Best of Both Worlds Approach to Revascularization
  • Chapter-073_Management of Coronary Stent Restenosis New Dimensions
  • Chapter-074_Saphenous Vein Grafts Intervention Challenges 2014
  • Section- VII
  • Chapter-075_Carotid Evaluation How to Do, 2014
  • Chapter-076_Carotid Intervention Current Status and Future Direction.
  • Chapter-077_Aortic Evaluation and Interventions Status 2014
  • Chapter-078_Peripheral Vascular Evaluation and Intervention
  • Chapter-079_Chronic Lower Limb Ischemia Management Strategies
  • Chapter-080_Erectile Dysfunction and Coronary Artery Disease
  • Section- VIII
  • Chapter-081_Biomarkers in Heart Failure Newer Horizon
  • Chapter-082_Echo and Diastolic Heart Failure
  • Chapter-083_BNP Evaluation Guidelines in CHF
  • Chapter-084_Anemia in Chronic Heart Failure
  • Chapter-085_When to Revascularize in Heart Failure
  • Chapter-086_Acute Decompensated Heart Failure
  • Chapter-087_Managing Comorbidities in Heart Failure
  • Chapter-088_CHF and CKD-Double Jeopardy How to Manage
  • Chapter-089_Heart Failure Management in Women Is it Different
  • Chapter-090_Left Ventricular Assist Devices New Frontiers 2014
  • Section- IX
  • Chapter-091_Approach to a Newly Diagnosed Hypertensive Patient
  • Chapter-092_Ambulatory BP Monitoring Is It Really Essential
  • Chapter-093_Cardiovascular Risk in Hypertension How to Manage It
  • Chapter-094_Role of Echocardiography in Hypertension
  • Chapter-095_Nonpharmacological Management of Hypertension 2014
  • Chapter-096_Resistant Hypertension Clinical Evaluation and Management
  • Chapter-097_Indian Practical Guidelines for Management of Hypertension
  • Chapter-098_Choosing the Right Drug for Your Hypertensive Patient A Look at Comorbidities
  • Chapter-099_Renal Denervation Present Status and Future Direction
  • Chapter-100_Recent Advances in Hypertension Management for Cardiovascular Disease Prevention
  • Chapter-101_Hypertension Paradoxes
  • Chapter-102_Hypertension Management Strategy in Renal Artery Stenosis
  • Chapter-103_Central Aortic Blood Pressure as a Prognostic Marker in Hypertension
  • Section- X
  • Chapter-104_TAVR Present Status and Challenges Ahead.

Ejemplares similares